VSee Health, Inc. (VSEE) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Analysten schätzen Gewinn pro Aktie (EPS) von $-0.03 und Umsatz von $0.01B für das nächste Geschäftsjahr.
Gewinn pro Aktie (EPS) Erfolgsbilanz: 2024: tatsächlich $-5.65 vs Schätzung $-0.03 (verfehlt -18733.3%). 2025: tatsächlich $-0.73 vs Schätzung $-0.36 (verfehlt -102.8%). Analysten-Genauigkeit: 25%.
GpA-Schätzungen — VSEE
25%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$5.65
vs Est –$0.03
▼ 99.5% off
2025
Actual –$0.73
vs Est –$0.36
▼ 50.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Umsatzschätzungen — VSEE
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.010B
vs Est $0.010B
▲ 3.2% off
2025
Actual $0.015B
vs Est $0.017B
▼ 13.7% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
